Premal Patel
Keine laufenden Positionen mehr
Karriereverlauf von Premal Patel
Ehemalige bekannte Positionen von Premal Patel
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 25.08.2021 | 01.04.2022 |
| LYELL IMMUNOPHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2018 | 01.04.2020 |
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01.09.2017 | 01.04.2018 |
| PFIZER, INC. | Corporate Officer/Principal | 01.08.2015 | 01.08.2017 |
Ausbildung von Premal Patel
| Rutgers State University of New Jersey | Undergraduate Degree |
| University of Washington | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Frankreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| EFFECTOR THERAPEUTICS, INC. | Health Technology |
| LYELL IMMUNOPHARMA, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
- Börse
- Insiders
- Premal Patel
- Erfahrung
